GenMark Diagnostics (GNMK) Should Be Bought On Tuesday's Weakness - Cowen
Tweet Send to a Friend
Cowen maintains Outperform on GenMark Diagnostics (NASDAQ: GNMK) price target of $17.00.Analyst Doug Schenkel comments "Subsequent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
